188 related articles for article (PubMed ID: 23173966)
21. Late renal artery stenosis after percutaneous renal denervation.
Lambert T; Blessberger H; Grund M; Steinwender C
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272
[TBL] [Abstract][Full Text] [Related]
22. Renal Afferents.
Frame AA; Carmichael CY; Wainford RD
Curr Hypertens Rep; 2016 Sep; 18(9):69. PubMed ID: 27595156
[TBL] [Abstract][Full Text] [Related]
23. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
Brinkmann J; Heusser K; Schmidt BM; Menne J; Klein G; Bauersachs J; Haller H; Sweep FC; Diedrich A; Jordan J; Tank J
Hypertension; 2012 Dec; 60(6):1485-90. PubMed ID: 23045466
[TBL] [Abstract][Full Text] [Related]
24. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
Prochnau D; Figulla HR; Surber R
Expert Rev Med Devices; 2013 Mar; 10(2):247-56. PubMed ID: 23480093
[TBL] [Abstract][Full Text] [Related]
25. Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension.
Azizi M; Steichen O; Frank M; Bobrie G; Plouin PF; Sapoval M
Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):293-9. PubMed ID: 22237510
[TBL] [Abstract][Full Text] [Related]
26. The role of renal denervation for the treatment of resistant hypertension.
McLellan AJ; Kistler PM; Walton AS; Schlaich MP
J Hum Hypertens; 2014 Apr; 28(4):218-23. PubMed ID: 24088716
[TBL] [Abstract][Full Text] [Related]
27. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
Schlaich MP
Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
[TBL] [Abstract][Full Text] [Related]
28. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
Bunte MC; Infante de Oliveira E; Shishehbor MH
JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
[TBL] [Abstract][Full Text] [Related]
29. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.
Papademetriou V; Rashidi AA; Tsioufis C; Doumas M
Circulation; 2014 Apr; 129(13):1440-51. PubMed ID: 24687645
[No Abstract] [Full Text] [Related]
30. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
[TBL] [Abstract][Full Text] [Related]
31. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
32. Recent Developments and Controversies in the Treatment of Resistant Hypertension.
Kühl C; Frey N; Frank D
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):178-86. PubMed ID: 27008634
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
Ewen S; Ukena C; Böhm M; Mahfoud F
Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
[No Abstract] [Full Text] [Related]
34. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
Mahfoud F; Tunev S; Ruwart J; Schulz-Jander D; Cremers B; Linz D; Zeller T; Bhatt DL; Rocha-Singh K; Böhm M; Melder RJ
Circ Cardiovasc Interv; 2014 Dec; 7(6):813-20. PubMed ID: 25336466
[TBL] [Abstract][Full Text] [Related]
35. The "resistant hypertension team": focus on a multidisciplinary approach to hypertension.
Potthoff SA; Rump LC; Vonend O
EuroIntervention; 2013 May; 9 Suppl R():R48-53. PubMed ID: 23732155
[TBL] [Abstract][Full Text] [Related]
36. Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?
Lüscher TF; Mahfoud F
Eur Heart J; 2014 Jul; 35(26):1706-11. PubMed ID: 24829361
[No Abstract] [Full Text] [Related]
37. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Voora R; Hinderliter AL
Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
[TBL] [Abstract][Full Text] [Related]
38. Renal nerve ablation for resistant hypertension: facts, fictions and future directions.
Bolignano D; Coppolino G
Rev Cardiovasc Med; 2019 Mar; 20(1):9-18. PubMed ID: 31184091
[TBL] [Abstract][Full Text] [Related]
39. Renal sympathetic nerve ablation for the management of resistant hypertension: an update.
Thorp AA; Larsen RN; Schlaich MP
Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):607-14. PubMed ID: 24100214
[TBL] [Abstract][Full Text] [Related]
40. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
